Overview
ABsize Inc. is a nanotechnology / nanomedicine company. Using its proprietary technology platform, Laser-induced Nanolization Technology (LiNTEC), ABsize is developing a novel nano-drug product pipeline, and partnering with pharma / biotech companies to developing their new products. LiNTEC is a non-thermal and non-contact physical process to nanolize poorly water-soluble molecules without chemical change, thereby increasing water solubility, improving bioavailability, and creating new formulations and delivery route.
Pharma industry, under great pressure of product patent expiry and generic competition, is urgently looking for best life cycle management strategy. Many marketed drugs and developing candidates have poor water-solubility and/or permeability.
LiNTEC is a platform technology that prepares long term stable nanoparticles of active pharmaceutical ingredient (API), resulting in greatly increased surface area and much improved solubility. Particle sizes are tunable and typically ranging from 1 to 300 nm. It is an effective solution to poor water-solubility problem and enables product opportunity of new formulation and delivery format. LiNTEC has been developed in Professor Masuhara’s Lab of Osaka University.
Management Team
Founder/CTO
Isamu Oh, Ph.D.,
LiNTEC inventor,
professor of Osaka University;
co-founder of Hanaphi and Neubrex.
CEO
CJ Wang, Ph.D.,
former VP Bus
Dev of VIVUS, Abmaxis and TaiGen
Biotech; VP Marketing and Bus
Dev of Cellomics; Dir. Licensing & Acquisition,
Packard Bioscience.
CFO
Annie Ma,
chairman/founder of Ample Luck
International Capital Group,
a boutique merchant bank; Co-founder
of Hansun Tech.
Company Profile
| Company Name | ABsize Inc. |
|---|---|
| Foundation | Jan 10th, 2007 |
| Our Office | 10 S. Third St, 3rd Floor,
San Jose CA, 95113, USA Tel. 1-408-351-3453 Fax. 1-408-521-0286 |
| Japan Office | S-cube 104, 130-42, Nagasone-cho, Kita-ku, Sakai-shi, Osaka, 591-8025, Japan Tel. +81-72-257-3505 Fax. +81-72-257-3503 →Access Map |
| CEO | CJ Wang, Ph.D. |
| Founder/CTO | Isamu Oh. Ph.D. |
| CFO | Annie Ma |
| Director | Teruki Sugiyama |
| Director | CJ Wang Ph.D. |
| Auditor | Yoshimaro Ito |
| Scientific Officer | Dr. Hiroshi Masuhara Professor
Emeritus of Osaka Univeristy Dr. Hideki Yoshikawa Chairman and Professor, Department of Orthopaedics, Osaka University Graduate School of Medicine Dr. Noriyuki Tsumaki, M.D. Osaka University Graduate School of Medicine |
| Current Investor VCs | Nippon Venture Capital, Future Venture Capital, Angel Capital, and Resona Capital, Co., Ltd. |
Chronology
In 1999
LiNTEC was pioneered by Prof. Masuhara, Osaka University
2007
January: ABsize, Inc Founded
in Osaka by Isamu Oh, CEO
March: Kobe
office opened
April: Kobe
laboratory opened
USA subsidiary
(launching in the end of 2007)
2008
February: ABsizeUSA Inc. was founded.
